NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ablynx 

Technologiepark 4

Ghent  Zwijnaarde  9052  Belgium
Phone: 32-0-9-261-06-32 Fax: 32-0-9-261-06-28


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Ablynx Achieves Third Milestone In Drug Discovery And Development Collaboration with Novartis AG 11/18/2009 10:20:10 AM    More...
Ablynx Provides Business Update For The Third Quarter 2009 11/10/2009 11:03:27 AM    More...
Ablynx Wins Award For 'Most Successful Early Phase Trial' 10/23/2009 11:01:04 AM    More...
Ablynx Provides An R&D Update And Announces Recent Technology Advances 10/19/2009 12:09:20 PM    More...
Ablynx And Domantis Limited Settle Their Dispute And Stop The Arbitration Process 10/12/2009 10:25:42 AM    More...
Ablynx Receives A Second Milestone Payment From Nanobody(R) Discovery And Development Alliance 10/5/2009 10:35:41 AM    More...
Ablynx Receives Milestone Payment As Part Of Its Strategic Alliance With Boehringer Ingelheim GmbH 10/1/2009 9:51:15 AM    More...
Wyeth Pharmaceuticals (New Jersey) (WYE) Initiates Phase II And Pays Ablynx Another Milestone of $4 Million In The Tnf-Alpha Nanobody(R) Collaboration 9/30/2009 10:24:26 AM    More...
Ablynx Announces Webcast Of Its Presentation At The UBS Global Life Sciences Conference In New York 9/15/2009 11:38:22 AM    More...
Ablynx Initiates Phase II Clinical Trial For Alx-0081 9/1/2009 10:37:05 AM    More...
1234567